Surgery Partners, Inc.
SGRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $12,500 | $135,300 | $87,000 | $70,700 |
| Dep. & Amort. | $152,600 | $118,100 | $114,800 | $98,800 |
| Deferred Tax | $131,500 | -$1,700 | $21,900 | $8,900 |
| Stock-Based Comp. | $33,300 | $17,700 | $18,400 | $17,400 |
| Change in WC | -$118,900 | -$62,300 | -$102,300 | -$149,100 |
| Other Non-Cash | $89,100 | $86,700 | $19,000 | $40,400 |
| Operating Cash Flow | $300,100 | $293,800 | $158,800 | $87,100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$90,400 | -$88,800 | -$80,600 | -$57,600 |
| Net Acquisitions | -$378,800 | -$128,900 | -$228,700 | -$280,400 |
| Inv. Purchases | -$1,700 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $4,600 | $0 | $0 | $0 |
| Other Inv. Act. | -$22,200 | -$7,900 | $1,400 | $6,300 |
| Investing Cash Flow | -$488,500 | -$225,600 | -$307,900 | -$331,700 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $450,400 | $19,500 | -$644,200 | -$43,800 |
| Stock Issued | $0 | $0 | $882,900 | $581,800 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$5,100 |
| Other Fin. Act. | -$188,400 | -$174,700 | -$196,600 | -$216,600 |
| Financing Cash Flow | $262,000 | -$155,200 | $42,100 | $316,300 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $73,600 | -$87,000 | -$107,000 | $71,700 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $195,900 | $282,900 | $389,900 | $318,200 |
| End Cash | $269,500 | $195,900 | $282,900 | $389,900 |
| Free Cash Flow | $209,700 | $205,000 | $78,200 | $29,500 |